The report "Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application) Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030", is projected to reach 61.2 billion in 2030 from USD 34.3 billion in 2025, at a CAGR of 12.3% during the forecast period.

Browse 312 market data Tables and 63 Figures spread through 303 Pages and in-depth TOC on "Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring (CGM), Insulin Delivery Devices (Insulin Pumps (Tethered), Insulin Pens, Pen Needles), Application) Disease Type (Type 1, Type 2), End User (Homecare/Self) - Global Forecast to 2030"

Download PDF  - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375

The diabetes care devices market is experiencing strong growth driven by the increasing prevalence of diabetes, which raises the demand for devices essential for daily disease management. The elderly population is more vulnerable to diabetes and its complications, resulting in greater use of blood glucose monitoring systems. Additionally, growing awareness about early detection and self-management to prevent complications has boosted demand for diabetes care devices. Continuous technological innovations, such as continuous glucose monitoring systems, insulin pumps, connected apps, and minimally invasive sensors like implant sensors, are making diabetes management more precise and patient-friendly.

On the basis of product type, the blood glucose monitoring segment is expected to account for the largest share of the global diabetes care devices market.

The global diabetes care devices market is divided into three main segments: blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. The blood glucose monitoring systems segment held the largest share of the market, driven by their strong functional benefits and crucial role in supporting effective diabetes management. These devices offer several advantages, such as real-time, continuous glucose data without the need for frequent pricks, which is gaining popularity among patients and healthcare providers. The integration with mobile apps makes it convenient for patients to monitor glucose level fluctuations and make informed decisions about the same.

On the basis of patient care settings, the self/home healthcare segment is expected to account for the largest share of the global diabetes care devices market.

The global diabetes care devices market is divided into categories based on patient care settings: self/home healthcare and hospitals & diabetes specialty clinics. Among these, the self/home healthcare segment is projected to hold the largest share of the market. Self-monitoring devices allow individuals to manage their conditions at home and reduce the need for frequent hospital or clinic visits. As people age, they prefer to handle their chronic conditions at home and avoid traveling to healthcare facilities. This daily self-management is crucial for preventing acute complications and enhancing long-term health outcomes. The rising global prevalence of diabetes, driven by lifestyle changes and an aging population, results in a large patient base.

On the basis of disease type, the type 2 diabetes segment is expected to account for the largest share of the global diabetes care devices market.

The rapid rise in type 2 diabetes is directly linked to obesity and sedentary lifestyles, especially abdominal fat, which leads to insulin resistance. Global obesity rates have increased due to changes in diet and decreased physical activity. Dietary habits such as consuming processed foods and unhealthy fats have contributed to the development of this condition. The risk is also higher in the aging population, and as the geriatric population grows, the number of individuals with this condition increases.

North America is expected to command the largest diabetes care devices market share during the forecast period.

The global market for surgical microscopes is divided into six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC Countries.

North America leads the diabetes care devices market, supported by a strong healthcare infrastructure, early adoption of advanced formulations, and high consumer demand for preventive and treatment products. The region's dominance is also reinforced by the presence of leading diabetes care device companies based in the US, which drive ongoing innovation and product availability. Elevated disposable income levels and growing health awareness among consumers in the US and Canada contribute to increased use of diabetes care devices. Additionally, the expanding distribution network of dental clinics, pharmacies, and retail outlets, along with continuous product premiumization, further reinforces North America's leadership in the global diabetes care market.

Key players

Prominent players in the Diabetes care devices market include  F. Hoffmann Roche Ltd (Switzerland), Abbott Laboratories (US), Medtronic (Ireland), Dexcom (US), Insulet Corporation (US), B Braun Se (Germany), Embecta Corp (US), Nipro (Japan), Senseonics (US), Ypsomed (Switzerland), i-Sens, Inc (South Korea), Tandem Diabetes Care, Inc (US), ACON LABORATORIES, INC (US), ARKRAY, INC(Japan), Terumo Corporation (Japan), Sinocare Inc (Japan), Waveform Diabetes (AgaMatrix) (US), Lifescan IP Holdings (US), SD Biosensor, Inc (South Korea), DeBiotech SA. (Switzerland), Sungshim Medical Co, Ltd (South Korea), Sooil Developments Co., Ltd (South Korea), Hindustan syringes and medical devices (India), Microgene Diagnostic Systems Pvt Ltd (India), Rossmax International Ltd (Taiwan)
Among other developments, these companies adopted strategies such as partnerships, collaborations, agreements, integrations, acquisitions, product launches, and expansions to strengthen their presence in the diabetes care devices market.

Don’t miss out on business opportunities in Diabetes Care Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.